PDB18 COST-EFFECTIVENESS OF ADD-ON PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) THERAPY IN DIABETIC VERSUS NON-DIABETIC PATIENTS WITH DYSLIPIDEMIA- A UK PERSPECTIVE
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67637-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)67637-1/fulltext
Title :
PDB18 COST-EFFECTIVENESS OF ADD-ON PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) THERAPY IN DIABETIC VERSUS NON-DIABETIC PATIENTS WITH DYSLIPIDEMIA- A UK PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67637-1&doi=10.1016/S1098-3015(10)67637-1
First page :
Section Title :
Open access? :
No
Section Order :
217